Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide for Fibromyalgia & Migraine
NCT00259636Phase 4Withdrawn
- Sponsor
- University of Pittsburgh
- Start
- Aug 2004
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in fibromyalgia (FM) and migraine comparing Zonisamide Arm with Placebo Arm (2 arms). Primary endpoints: Visual Analogue Score at 8 weeks, Tender Point Count at 8 weeks and 1 more. Planned start Aug 2004; status: withdrawn.
02
Drugs
zonisamide
03
Conditions
fibromyalgia (FM)migraine
Beyond the preview
Go deeper on NCT00259636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259636.